Log In
Print
BCIQ
Print
Print this Print this
 

TTI-1612

  Manage Alerts
Collapse Summary General Information
Company Trillium Therapeutics Inc.
DescriptionRecombinant protein with cytoprotective and anti-inflammatory effects
Molecular Target
Mechanism of Action 
 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of Development
More More
 Archive Items are loading loading
Get a free BioCentury trial today